Application of noninvasive phagocytic cellular assays using autologous monocytes to assess red cell alloantibodies in sickle cell patients

Transfusion and Apheresis Science

Volumn 31, Issue 1, 2004, Pages 29-35

  Fabron Jr , Antonio ^a   Baleotti Jr , Wilson ^a   De Mello, Adriana B ^b   Chiba, Akemi K ^b   Kuwano, Sachie ^b   Figueiredo, Maria S ^b   Bordin, José O ^b  

^a FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alloimmunization; Chemiluminescence test; Monocyte monolayer assay; Sickle cell anemia

Indexed keywords

ALLOANTIBODY;

ALLOIMMUNIZATION; ARTICLE; BLOOD TRANSFUSION; CELL ASSAY; CHEMOLUMINESCENCE; COOMBS TEST; ERYTHROCYTE; HEMOLYSIS; HUMAN; MONOCYTE; PHAGOCYTOSIS; PREDICTION; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; ERYTHROCYTES; HUMANS; ISOANTIBODIES; LEUKOCYTE TRANSFUSION; MIDDLE AGED; MONOCYTES; PHAGOCYTES; TRANSPLANTATION, AUTOLOGOUS;

EID: 3843067666     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2004.02.009     Document Type: Article

References (18)

1. Wayne A.S., Kevy S.V., Nathan D.G. Transfusion management of sickle cell disease. Blood. 81:1993;1109-1123
2. Vichinsky E.P. Current issues with blood transfusions in sickle cell disease. Semin. Hematol. 38:2001;14-22
3. Aygun B., Padmanabhan S., Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 42:2002;37-43
4. Daniels G., Poole J., Silva M., Callaghan T., MacLennan S., Smith N. The clinical significance of blood group antibodies. Transfus. Med. 12:2002;287-295
5. Nance S.J., Nelson J.M., Horenstein J., Arndt P.A., Platt L.D., Garratty G. Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn. Am. J. Clin. Pathol. 92:1989;89-92
6. Lucas G.F., Hadley A.G., Nance S.J., Garratty G. Predicting hemolytic disease of newborn: a comparison of the monocyte monolayer assay and chemiluminescence test. Transfusion. 33:1993;484-487
7. Hadley A.G., Wilkes A., Poole J., Arndt P., Garratty G. A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus. Med. 9:1999;337-342
8. Downing I., Bromilow I.M., Templeton J.G., Fraser R.H. A retrospective study of red cell maternal antibodies by chemiluminescence. Vox Sang. 71:1996;226-232
9. b. Transfusion. 38:1998;1026-1029
10. b. Transfusion. 41:2001;611-614
11. Strachan A.J., Willians B., Mohabir L., Rowe G.P. Human monoclonal antibodies: assessment of functional activity by chemiluminescence and RhD antibody quantification. Transfus. Clin. Biol. 6:1996;483-487
12. Schonewille H., Haak H.L., Van Zijl A.M. RBC antibody persistence. Transfusion. 40:2000;1127-1131
13. Engelfriet C.P., Reesink H.W. What is the best technique for the detection of red cell alloantibodies? Vox Sang. 69:1995;292-300
14. Dhingra-Kumar N., Duguid J.K., Bromilow I.M. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay. Indian J. Med. Res. 102:1995;71-76
15. Nance S.J., Arndt P., Garratty G. The effect of fresh normal serum on monocyte monolayer assay reactivity. Transfusion. 28:1988;398-399
16. Issit P.D., Gutgsell N.S., Hervis L. Some stored antibodies give unreliable results in the monocyte monolayer assay. Transfusion. 28:1988;399-400
17. Hadley A.G., Kumpel B.M. Phagocytosis by human monocytes of red cell sensitized with monoclonal IgG1 and IgG3 anti-D. Vox Sang. 57:1989;150-151
18. Larson P.J., Thorp J.M., Miller R.C., Hoffmann M. The monocyte monolayer assay: a noninvasive technique for predicting the severity of in utero hemolysis. Am. J. Perinat. 12:1995;157-160